Our Team

Founder and Chief Executive Officer of ImmuMap Services, Thomas Mørch Frøsig, is PhD in tumor immunology and has years of experience with advanced T cell detection techniques. Thomas’ work in this field has resulted in high-impact scientific publications on mapping T cell reactivity to cancer through the use of multicolor flow cytometry and on developing new techniques for the generation of MHC multimer reagents.

Founder and Chief Business Officer (CBO), Søren Nyboe Jakobsen, previously worked for Immudex with responsibilities in areas of technology innovation, technology development, IP securing, new products development, business development, marketing, online marketing and branding. He has major experience with the production and use of MHC Dextramers. Søren is the inventor/co-inventor of several issued patents on molecular-display techniques, molecular selection and high-throughput screening techniques including high-throughput epitope discovery techniques.

Founder Sine Reker Hadrup, PhD, is internationally recognized for her work on standardizing the use of MHC multimers and has built a successful research career on using flow cytometry for characterizing specific T cell populations. Sine Reker Hadrup is the inventor of a groundbreaking high-throughput technology for next-generation multiplex detection of antigen-specific T cells using DNA-barcode labeled MHC multimers. Sine has published >50 peer-review articles in the field of T cell detection and immune recognition of cancer.

Founder Jørgen Schøller, is co-inventor of MHC Dextramers. On this basis Jørgen co-founded Immudex, the company producing MHC Dextramers, and served as Chief Scientific Officer until 2012. He initiated the spin-out process of Immudex from the diagnostics company DAKO. At Immudex Jørgen was deeply involved in marketing and sales as well as in the development of new products. Jørgen Schøller is also co-founder of the company FIDA-Tech developing a new assay technology using flow-induced dispersion analysis.